Fatty liver after long-term gallbladder removal
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at whether having your gallbladder removed several years ago may be linked to fatty liver disease. Fatty liver is when extra fat builds up in the liver, which can affect how well it works. By joining, you could help researchers better understand this connection and what it might mean for your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- Your body mass index (BMI) must be over 25, meaning you have excess weight.
- You must not have chronic kidney failure.
- You must not have liver cirrhosis or sudden (acute) liver problems.
- If you are a woman, you cannot be pregnant or breastfeeding.
- Your gallbladder removal surgery must have happened at least 5 years ago.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what causes fatty liver disease (a buildup of fat in the liver) to develop in people who have had a liver transplant but whose original disease was not fatty liver. If you've had a transplant, you might join to help doctors understand and prevent this condition.
This study looks at how common obesity is in people with fatty liver disease (a condition where fat builds up in the liver). It aims to understand the relationship between these two conditions better, which might lead to improved care and prevention.
This study looks at how fatty liver disease may predict future liver health in people with severe weight gain. It compares people who are planning bariatric (weight-loss) surgery with similar people who are not, to better understand who may be at higher risk.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study looks at how a specific gut bacteria (Ruminococcus gnavus) and the chemicals it makes are linked to a type of fatty liver disease called MAFLD. By joining, you'll help researchers understand this connection, which may lead to better treatments in the future.
This study aims to better classify a common type of fatty liver disease (called MAFLD) using liver biopsy samples. It may help researchers understand different subtypes of the disease and could lead to more personalized care.
Hear when a new Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Post-cholecystectomy Metabolic Changes -Hepatic Steatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.